Type 2 Diabetes Information Center Archive
The FDA has approved semaglutide injection as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Primary care referral to Weight Watchers meetings is associated with weight loss, HbA1c reduction.
Statins are associated with an increased risk for developing type 2 diabetes, especially for high-risk individuals.
Type 2 diabetes risk is increased in young adults through antidepressant use, specifically the duration of use and the cumulative dose.
CBGT did not prevent overweight and obese patients with type 2 diabetes from regaining weight lost during weight loss programs.
Type 2 diabetes is greater with second-generation antipsychotics than with non-second-generation antipsychotic psychotropic medications for patients aged 6 to 25 years.
After the inclusion of recent negative studies, a statistically significant association between AD use and diabetes was observed.
Sleep duration for 1 hour longer was associated with lower BMI, fat mass, insulin resistance, and fasting glucose but had no effect on HbA1c or cardiovascular risk.
Lifestyle interventions maintain glycemic control in patients with type 2 diabetes.
Women who experienced early menopause were 2.4 times more likely to develop diabetes.
Adulthood weight gain is associated with an increased risk of major chronic diseases and mortality.
The annual screening could decrease negative health outcomes and may be a cost-effective way to reduce complications.
Degludec is noninferior to glargine regarding the incidence of major cardiovascular events among patients with type 2 diabetes.
Compared with current use of metformin + sulfonylurea, the use of thiazolidinediones + metformin was associated with an increased risk of community-acquired pneumonia.
Adolescents with type 2 diabetes decreased HbA1c levels after using insulin pump therapy for a 3-month period.
A high BMI is associated with an increased risk for severe liver disease, and the risk is higher in those who also have type 2 diabetes mellitus.
The Stepping Up model of care produced a clinically and significantly significant improvement in HbA1c among adults with type 2 diabetes managed in primary care.
Suboptimal intake of 10 specific dietary factors is associated with a substantial proportion of deaths due to heart disease, stroke, or type 2 diabetes.
Vildagliptin lowers blood pressure and elevates heart rate, while metformin increases heart rate with no effect on blood pressure.
Applying necessary lifestyle changes as well as incorporating pharmaceutical drugs will improve diabetes in patients compared to drugs alone.
A 63-year-old man with type 2 diabetes was admitted to the hospital to undergo right robotic partial nephrectomy.
Researchers observed a reduced risk of all-cause mortality and CVD with dapagliflozin and a lower risk of mortality with dipeptidyl-peptidase-4 inhibitors.
Pharmacotherapy and combination therapy may be a better alternative to the ACP's diabetes treatment guidelines.
Fasting glucose is specific but not sensitive, and HbA1c is neither sensitive nor specific.
Men with diabetes, but not women, had excess mortality risk associated with depression and anxiety.
The ACP has updated the 2012 guideline to provide clinical recommendations of oral pharmacologic treatment of type 2 diabetes.
Women may have a higher risk of type 2 diabetes with low levels of sex hormone-binding globulin and high levels of total estradiol.
Intensification of therapy within 6 months of metformin monotherapy failure resulted in rapid attainment of A1c goals.
A target intake of at least 500 mg/d is recommended to combat sight-threatening diabetic retinopathy.
Canagliflozin 100 mg or 300 mg slowed kidney decline compared with glimepiride.
The once-daily injection works to improve glycemic control.
A patient with type 2 diabetes is undergoing dialysis and needs to control his HbA1c levels while fasting during Ramadan.
New guidelines support use of metabolic surgery as standard treatment option for type 2 diabetes, obesity
A panel of experts has recommended that metabolic surgery be included as a treatment option for patients with type 2 diabetes and obesity.
Metformin more effective than sulfonylureas for reducing cardiovascular mortality in diabetes patients
Compared with other drugs for type 2 diabetes, metformin is superior for reducing the risk of cardiovascular mortality.
The FDA will add warnings about heart failure risk to the labels of type 2 diabetes medicines containing saxagliptin and alogliptin.
A patient with type 2 diabetes presents with elevated microalbumin levels and a recent history of elevated glucose due to bedtime snacking.
High body weight percentage may increase mortality, and poor physical fitness in youth can increase diabetes risk later in life.
The CPAP group had a larger decrease in HbA1c levels after 6 months.
The ADA has published the 2016 Standards of Medical Care in Diabetes that outline the best practices for diabetes care and management.
Once-weekly GLP-1RAs reduced HbA1c and fasting plasma glucose.
Current evidence is inadequate to determine how DPP-4 inhibitors affect the risk of heart failure in patients with type 2 diabetes.
A statin plus extended-release niacin reduces apoB-48 concentrations in patients with type 2 diabetes, compared with a statin alone.
More than 60% of the 31,545 patients analyzed between 2001 and 2013 underwent HbA1c at least four times per year.
Breastfeeding for 2 or more months may reduce the odds of developing type 2 diabetes in mothers previously diagnosed with gestational diabetes.
Patients with type 2 diabetes and severe insulin resistance may require large doses of insulin to achieve glycemic control.
Three renal biomarkers - AKI, albuminuria, and eGFR - can predict adverse outcomes in diabetes, according to a study published in Diabetes Care.
A meta-analysis of 88 studies show a concrete link between current smokers and an elevated risk of type 2 diabetes.
Clinicians should screen all asymptomatic, obese adults for abnormal blood glucose levels, says the U.S. Preventative Services Task Force.
Daytime sleepiness and long naps may be associated with significantly increased risks of developing type 2 diabetes.
Almost half of adults in the United States have either type 2 diabetes or prediabetes, though many are undiagnosed.
SGLT2 receptor blockers are only approved for type 2 diabetes.
Glyxambi is adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.
The FDA released a warning that DPP-4 inhibitors may lead to severe joint pain in patients with T2DM.
Using long-acting insulin in type 2 diabetes does not increase the risk for acute myocardial infarction.
People with type 2 diabetes who skipped breakfast had a higher risk of postprandial hyperglycemia.
Eating carbohydrates last helped lower glucose levels, especially if vegetables and proteins were eaten first.
After adjustment for age and sex, standardized mortality ratios (SMRs) were higher in type 1 and type 2 diabetes for all outcomes.
Current insulin treatments and new agents to manage diabetes may be prohibitively expensive for patients without health insurance.
Creating better long-term, sustained relationship between patients and providers improves patient satisfaction and adherence to treatment.
With metformin, mean score for gastrointestinal side effects higher for gastritis subjects over four weeks.
The glycated hemoglobin in the intensive control group was 6.9%, on average. For those on standard care, the glycated hemoglobin average was 8.4%.
The vegan group had lost 15 pounds, on average, versus about one pound in the comparison group.
Patients with diabetes who are prescribed sodium glucose co-transporter type 2 inhibitors are at increased risk for developing a mycotic infection.
Although overweight patients were more likely to develop heart disease, overweight patients, however, were less likely to die, compared with obese and normal-weight individuals.
Drinking water, unsweetened tea or coffee instead lowered risk by 25%.
Treatment of impaired fasting glucose, impaired glucose tolerance can delay progression to diabetes.
Add-on thiazolidinedione decreased HbA1c significantly better than add-on glimepiride among patients inadequately controlled on metformin + exenatide, but there were significant increases in BMI and systolic blood pressure.
From all 10 lifestyle intervention groups, the pooled within-group effect on weight (3,063 patients) was −5.33 kg.
Alcohol consumption did not influence estimated insulin sensitivity or fasting glucose but was correlated with reductions in HbA1c and fasting insulin concentrations.
Five-year survival for breast cancer patients with diabetes was 15% lower than for those without diabetes.
Patients who were prescribed at least two courses of four types of antibiotics -- penicillins, cephalosporins, quinolones, and macrolides -- were more likely to develop diabetes.
Both bariatric surgery and intensive weight management yielded similar improvements in HbA1c, weight loss and quality of life.
For every 30 minutes of lost weekday sleep, the risk of obesity and insulin resistance increased substantially.
A patient, aged 60 years, was admitted to the hospital to undergo renal transplant therapy. He had a history of type 2 diabetes for 15 years.
Testing Americans at risk for type 2 diabetes is the first step, experts said.
About half of the children enrolled in the study had elevated blood pressure or dyslipidemia, and 14% had diabetes.
Not recommended as first-line treatment for patients inadequately controlled on diet and exercise.
Adjunct to diet and exercise to improve glycemic control in adults with T2DM who are not adequately controlled on a regimen containing metformin or canagliflozin.
Two pathways of child growth that were associated with the development of T2D, found the researchers.
When creating outpatient diabetes management plan, the patient's inpatient medication regimen should be considered but not necessarily replicated.
In 2012, the ADA and the EASD published a position statement on the management of hyperglycemia in patients with T2DM. In January, 2015, the ADA and EASD issued an update to the original 2012 statement.
The average weight loss after a year was about 6 pounds for the AHA dieters and 4.6 pounds for the high-fiber followers, but all of the participants experienced lower blood pressure and reduced blood glucose levels.
Each decrease of 10 mm mercury (Hg) in systolic blood pressure reading reduced the risk of early death by 13%.
The greater the number and severity of post-traumatic stress disorder symptoms, the greater a patient's risk of type 2 diabetes.
The FDA has approved empagliflozin/linagliptin tablets as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes when both empagliflozin and linagliptin are appropriate treatments.
Reducing the intake of added sugars may help reduce diabetes-related morbidity, researchers suggest.
Many older adults with diabetes and comorbid medical problems may be over treated.
Glucomannan can help treat obesity and comorbid conditions of type 2 diabetes, heart disease, and early mortality.
A patient, aged 57 years, was admitted to the hospital to undergo gastric bypass surgery. He had a history of type 2 diabetes for ten years.
A majority of patients with diabetes are worried about experiencing hypoglycemia, with many being uncertain about how to manage the condition.
Even in patients who exercise regularly, greater sedentary time is associated with an increased risk of adverse health outcomes.
Eisai has launched a new savings card for lorcaserin (Belviq) to increase the affordability and accessibility of the weight-loss drug.
Decreased vegetable protein intake and increased dietary acid load were associated with prevalence of metabolic syndrome.
A patient with type 2 diabetes for ten years experienced three recent hospitalizations and a COPD exacerbation that required an increase in maintenance steroids.
The Maestro Rechargeable System has been approved by the FDA to treat obese patients with at least one obesity-related condition.
One-third fewer patients died among the group that reported consuming the most whole grains per day.
The Grain Foods Foundation's Glenn Gaesser, PhD, discusses how whole grains benefit patients.
Pioglitazone was not linked to bladder cancer in an extensive analysis.
Standards include new recommendations for statin treatment based on individual risk profile
A patient diagnosed with type 2 diabetes, hypertension, hyperlipidemia presents to the foot clinic after one month of swelling, redness, and warmth in the left foot.